Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Ascorbic Acid for Fatigue in Early Stage Breast Cancer
NCT02521077Phase 2Withdrawn
- Sponsor
- City of Hope Chicago
- Start
- May 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ascorbic acid in fatigue, sponsored by City of Hope Chicago. Planned start May 2017; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT02521077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02521077.